[On the circulatory pharmacology of the new beta-adrenergic agent dobutamine (author's transl)].
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001786:Blood Glucose / Q000378:metabolism; D002395:Catecholamines / Q000494:pharmacology*; D002415:Cats; D004280:Dobutamine / Q000494:pharmacology*; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D011773:Pyruvates / Q000097:blood; D051381:Rats; D013045:Species Specificity; D014590:Uterine Contraction / Q000187:drug effects
D001786:Blood Glucose; D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D011773:Pyruvates; D004280:Dobutamine
Zur Kreislaufpharmakologie des neuen beta-adrenergen Wirkstoffes Dobutamin.